Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinibSusannah O'Sullivan, Anne Horne, Diana Wattie, et al.
Arthritis Research & Therapy|November 5, 2020
Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteersNicola Dalbeth, Jordyn Allan, Gregory D Gamble, et al.
Annals of the Rheumatic Diseases|August 24, 2017
Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension studyLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Clinical Pharmacokinetics|July 28, 2025
The Influence of Patient Factors on the Population Pharmacokinetics of Colchicine: Implications for Safe and Effective DosingDaniel F B Wright, Hailemichael Z Hishe, Nicola Dalbeth, et al.
Arthritis Research & Therapy|December 23, 2017
The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
Rheumatology (Oxford, England)|August 15, 2018
Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trialLisa K Stamp, Peter T Chapman, Murray Barclay, et al.
The New Zealand Medical Journal|May 7, 2026
Agreement between self-reported fractures in a clinical trial with New Zealand Accident Compensation Corporation claims dataMark J Bolland, Zaynah Nisa, Anna Mellar, et al.
Arthritis Research & Therapy|November 18, 2018
How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based doseLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Annals of the Rheumatic Diseases|March 19, 2017
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with goutLisa K Stamp, Peter T Chapman, Murray L Barclay, et al.
Clinical Rheumatology|November 2, 2012
The experience and impact of gout in Māori and Pacific people: a prospective observational studyNicola Dalbeth, Meaghan E House, Anne Horne, et al.
Pageof 13